JP7797759B2 - Urinary carotenoid testing method, urine collection kit, and method for estimating serum carotenoid concentration or vegetable intake - Google Patents
Urinary carotenoid testing method, urine collection kit, and method for estimating serum carotenoid concentration or vegetable intakeInfo
- Publication number
- JP7797759B2 JP7797759B2 JP2022063757A JP2022063757A JP7797759B2 JP 7797759 B2 JP7797759 B2 JP 7797759B2 JP 2022063757 A JP2022063757 A JP 2022063757A JP 2022063757 A JP2022063757 A JP 2022063757A JP 7797759 B2 JP7797759 B2 JP 7797759B2
- Authority
- JP
- Japan
- Prior art keywords
- urine
- carotenoid
- urinary
- concentration
- urine collection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Description
本発明は、対象者の尿中カロテノイドの検査方法と、採尿キット、尿中カロテノイド濃度から血清中カロテノイド濃度または野菜摂取量を推定する方法に関する。 The present invention relates to a method for testing carotenoids in a subject's urine, a urine collection kit, and a method for estimating serum carotenoid concentrations or vegetable intake from urinary carotenoid concentrations.
日本国厚生労働省は、健康を維持するために、野菜を1日あたり350g以上摂取することを推奨としているが、令和元年度の平均摂取量は280.5gと不足している(非特許文献1)。
野菜は、ビタミン、ミネラル、食物繊維などとともに、カロテノイドを豊富に含む。
カロテノイドは、8個のイソプレン単位が結合して構成された基本骨格(化学式C40H56)を備える化合物であり、この基本骨格中の共役二重結合により400~500nmの間の可視光を吸収して黄色、橙色、赤色等を呈する天然の色素成分である。カロテノイドは、これまでに600種類以上の化合物が同定されているが、例えば、ニンジンに多く含まれるβカロテン、トマトに多く含まれるリコピン、ほうれん草などに多く含まれるルテインなどがよく知られている。カロテノイドは、抗酸化作用を有することが知られているが、活性酸素を消去する働きを有することから、癌、心筋梗塞、脳卒中、生活習慣病等の予防効果が期待されている。
The Ministry of Health, Labour and Welfare of Japan recommends consuming at least 350g of vegetables per day to maintain good health, but the average intake in 2019 was 280.5g, which is insufficient (Non-Patent Document 1).
Vegetables are rich in carotenoids, along with vitamins, minerals, dietary fiber, etc.
Carotenoids are compounds with a basic skeleton (chemical formula C 40 H 56 ) composed of eight bonded isoprene units, and are natural pigment components that absorb visible light in the 400-500 nm range due to the conjugated double bonds in this basic skeleton, resulting in yellow, orange, red, and other colors. More than 600 carotenoid compounds have been identified to date, with well-known examples including beta-carotene, which is abundant in carrots, lycopene, which is abundant in tomatoes, and lutein, which is abundant in spinach. Carotenoids are known to have antioxidant properties, and because they have the ability to scavenge active oxygen, they are expected to have preventive effects against cancer, myocardial infarction, stroke, lifestyle-related diseases, and the like.
カロテノイドは、動物や微生物中にも存在するが、ヒトが摂取するカロテノイドのほとんどは野菜由来である。そのため、体内のカロテノイド濃度から野菜摂取量を推定することができ、例えば、特許文献1には、非侵襲的に測定した皮膚カロテノイド値から野菜摂取量を推定し、野菜摂取を啓発する方法が提案されている。この方法は、非侵襲的ではあるが、摂取したカロテノイドが皮膚に蓄積するには2~4週間程度かかるため、得られる皮膚カロテノイド値データは、直前の野菜摂取量を反映したものではない。
また、非特許文献2、3には、尿中カロテノイド濃度と血漿中(血清)カロテノイド濃度とが相関関係を有し、尿中カロテノイド濃度は血清中の濃度を反映しているが、尿中βカロテノイド濃度は、血清中カロテノイド濃度の1/1000以下であることが報告されている。そして、尿中のカロテノイド濃度は非常に薄いため、40mlという大量の尿から有機溶媒で抽出した画分を測定に利用している。
Although carotenoids are also present in animals and microorganisms, most of the carotenoids ingested by humans are derived from vegetables. Therefore, vegetable intake can be estimated from the carotenoid concentration in the body. For example, Patent Literature 1 proposes a method for estimating vegetable intake from non-invasively measured skin carotenoid values and promoting vegetable intake. Although this method is non-invasive, it takes about 2 to 4 weeks for ingested carotenoids to accumulate in the skin, and therefore the obtained skin carotenoid value data does not reflect the immediately preceding vegetable intake.
Furthermore, Non-Patent Documents 2 and 3 report that there is a correlation between urinary carotenoid concentrations and plasma (serum) carotenoid concentrations, and that while urinary carotenoid concentrations reflect serum concentrations, urinary β-carotenoid concentrations are 1/1000 or less of serum carotenoid concentrations. Furthermore, because the carotenoid concentration in urine is very low, fractions extracted with organic solvents from a large volume of urine (40 ml) are used for measurement.
尿中カロテノイド濃度を簡便に検出可能な尿検査方法を提供することを課題とする。 The objective of this study is to provide a urine testing method that can easily detect urinary carotenoid concentrations.
本発明の主な構成は、次のとおりである。
1.アルカリ性添加剤を添加した尿検体を用いて、尿中カロテノイド濃度を検出することを特徴とする尿検査方法。
2.前記尿検体が、pHが8.0以上であることを特徴とする1.に記載の尿検査方法。3.尿採取容器とアルカリ性添加剤とを有し、尿中カロテノイド濃度測定用であることを特徴とする採尿キット。
4.1.または2.の尿検査方法により検出した尿中カロテノイド濃度から、血清中カロテノイド濃度または野菜摂取量を推定する方法。
The main configuration of the present invention is as follows.
1. A urine testing method characterized by detecting the concentration of carotenoids in urine using a urine specimen to which an alkaline additive has been added.
2. The urine test method according to 1., wherein the urine sample has a pH of 8.0 or higher. 3. A urine collection kit comprising a urine collection container and an alkaline additive, and used for measuring urinary carotenoid concentrations.
4. A method for estimating serum carotenoid concentrations or vegetable intake from urinary carotenoid concentrations detected by the urine testing method in 1. or 2.
本発明の検査方法は、測定試料の前処理にかかる時間を短縮することができる。本発明の検査方法は、採尿から測定までの時間を短縮することができるため、尿検体の変質を防ぐことができる。本発明の検査方法は、少量の尿から尿中カロテノイド濃度を検出することができ、採尿、および採取した尿の郵送が容易であり、また、廃棄物の量を削減することができる。 The testing method of the present invention can shorten the time required for pre-treatment of the measurement sample. The testing method of the present invention can shorten the time from urine collection to measurement, thereby preventing deterioration of the urine sample. The testing method of the present invention can detect urinary carotenoid concentrations from small amounts of urine, simplifies urine collection and mailing of collected urine, and reduces the amount of waste.
尿は、糖、タンパク、塩類等の多様な成分を含む。尿検査により、尿中に含まれる成分の量的変化、質的変化、異常物質の有無等を調べることにより、腎臓、尿管、膀胱のみならず、肝臓、胆のう等の状態を知ることができる。尿検査項目の一つに沈渣の検査があるが、これは、尿中に含まれる赤血球、白血球、尿酸結晶、細菌等の固形分を沈殿させて、その組成や量を検査するものである。
本発明者らは、鋭意研究の結果、尿中カロテノイドが沈殿に含まれることにより、液中のカロテノイド濃度が低下するため、検出感度が低下して定量が困難となっていることを見出し、本発明を完成させるに至った。
Urine contains a variety of components, including sugar, protein, and salts. Urine tests can reveal the condition of not only the kidneys, ureters, and bladder, but also the liver and gallbladder by examining quantitative and qualitative changes in the components in the urine and the presence or absence of abnormal substances. One of the urine test items is a sediment test, which involves precipitating solid components in the urine, such as red blood cells, white blood cells, uric acid crystals, and bacteria, and examining their composition and quantity.
As a result of extensive research, the inventors discovered that when urinary carotenoids are contained in precipitates, the concentration of carotenoids in the liquid decreases, reducing detection sensitivity and making quantification difficult, leading to the completion of the present invention.
・尿検査方法
本発明の尿検査方法は、アルカリ性添加剤を添加した尿検体を用いて、尿中カロテノイド濃度を検出することを特徴とする。
- Urine Test Method The urine test method of the present invention is characterized by detecting the concentration of carotenoids in urine using a urine sample to which an alkaline additive has been added.
本発明の尿検査方法で使用するアルカリ性添加剤としては、水溶液がアルカリ性を呈するものであれば特に制限されず、例えば、アンモニア、水酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭酸カリウム等のアルカリ金属塩、水酸化カルシウム、水酸化マグネシウム等のアルカリ土類金属塩、トリエチルアミン、トリエタノールアミン、トリス(ヒドロキシメチル)アミノメタン、ピリジン類、イミダゾール類等のアミン系有機化合物、アルギニン、リシン等の塩基性タンパク質等を挙げることができる。これらの中で、臭気や安全性の点から、トリス(ヒドロキシメチル)アミノメタン、イミダゾール、アルギニンが好ましい。 The alkaline additive used in the urine testing method of the present invention is not particularly limited as long as it provides an alkaline aqueous solution. Examples include alkali metal salts such as ammonia, sodium hydroxide, potassium hydroxide, sodium carbonate, and potassium carbonate; alkaline earth metal salts such as calcium hydroxide and magnesium hydroxide; amine-based organic compounds such as triethylamine, triethanolamine, tris(hydroxymethyl)aminomethane, pyridines, and imidazoles; and basic proteins such as arginine and lysine. Of these, tris(hydroxymethyl)aminomethane, imidazole, and arginine are preferred from the standpoints of odor and safety.
尿にアルカリ性添加剤を添加することにより、沈殿の少なくとも一部を溶解して減らすことができ、沈殿に含まれるカロテノイド量を減らし、液中に含まれるカロテノイド量を高く保つことができる。アルカリ性添加剤を添加した尿検体は、pHが8.0以上であることが好ましく、8.5以上であることがより好ましく、8.8以上であることがさらに好ましく、9.0以上であることがよりさらに好ましい。 By adding an alkaline additive to urine, it is possible to dissolve and reduce at least a portion of the precipitate, thereby reducing the amount of carotenoids contained in the precipitate and maintaining a high amount of carotenoids in the liquid. The pH of a urine sample to which an alkaline additive has been added is preferably 8.0 or higher, more preferably 8.5 or higher, even more preferably 8.8 or higher, and even more preferably 9.0 or higher.
そして、本発明の尿検査方法は、液中のカロテノイド濃度を高く保つことができるため、少量の尿で尿中カロテノイド濃度を検出することができる。本発明において、尿中カロテノイド濃度を検出するために必要な尿の量は、検出可能な尿検体を作成可能であれば特に制限されないが、10ml以下であることが好ましく、5ml以下であることがより好ましく、3ml以下であることがさらに好ましく、2ml以下であることがよりさらに好ましい。 Furthermore, the urine testing method of the present invention can maintain a high carotenoid concentration in the liquid, making it possible to detect urinary carotenoid concentrations with a small amount of urine. In the present invention, the amount of urine required to detect urinary carotenoid concentrations is not particularly limited as long as a detectable urine sample can be produced, but is preferably 10 ml or less, more preferably 5 ml or less, even more preferably 3 ml or less, and even more preferably 2 ml or less.
・採尿キット
本発明の尿検査方法は、少なくとも、尿採取容器とアルカリ性添加剤とを有する採尿キットを用いることが好ましい。
尿採取容器は、病院や検査機関等で実施されている尿検査のために使用される尿中成分の変質を引き起こさない形状、材質であれば特に限定されず用いることができる。尿採取容器に採取できる尿の量は、尿検体を作成可能な量であれば特に制限されないが、例えば、10ml以下である。尿採取容器は、直接尿を採取できる形態のものでもよく、採尿カップ等に採取した尿を移し替える形態のものでもよい。また、尿採取容器は、所定量の尿が採取できるように目盛りが設けられていることが好ましい。さらに、尿採取容器は、密封が可能であることが、尿を封入した尿採取容器を病院や検査機関に郵送して検査することが可能であり、被検者が病院や保健所に行く必要がないため好ましい。採尿キットは、尿採取容器とアルカリ性添加剤の他に、外箱、検査手順や注意事項等を記載した説明書、採尿カップ、チャック付ビニール袋、被検者の氏名、生年月日、性別等の情報を記載する尿検査依頼書、返信用封筒等を有することができる。
Urine Collection Kit The urine test method of the present invention preferably uses a urine collection kit having at least a urine collection container and an alkaline additive.
Urine collection containers can be used for urine tests conducted in hospitals, testing institutions, etc., and are not particularly limited in shape or material as long as they do not cause deterioration of urinary components. The amount of urine that can be collected in a urine collection container is not particularly limited as long as it is an amount that allows for the preparation of a urine specimen, but is, for example, 10 ml or less. The urine collection container may be designed to allow direct urine collection or to transfer collected urine to a urine collection cup, etc. It is also preferable that the urine collection container be graduated so that a predetermined amount of urine can be collected. Furthermore, it is preferable that the urine collection container be sealable, because the urine-filled urine collection container can be mailed to a hospital or testing institution for testing, eliminating the need for the subject to visit a hospital or public health center. In addition to the urine collection container and alkaline additive, the urine collection kit may include an outer box, an instruction manual describing the test procedure and precautions, a urine collection cup, a zippered plastic bag, a urine test request form containing information such as the subject's name, date of birth, and gender, a return envelope, etc.
ここで、健常者の尿のpHは、摂取した食物等に応じて4.5~8の間で変動する。そのため、アルカリ性添加剤の量は、所定量の尿検体を作成する場合に、pHが8.0以上となる量であることが好ましく、8.5以上となる量であることがより好ましく、8.8以上となる量であることがさらに好ましく、9.0以上となる量であることがよりさらに好ましい。 The pH of urine from healthy individuals varies between 4.5 and 8 depending on the food ingested, etc. Therefore, the amount of alkaline additive used when preparing a predetermined amount of urine sample is preferably an amount that results in a pH of 8.0 or higher, more preferably an amount that results in a pH of 8.5 or higher, even more preferably an amount that results in a pH of 8.8 or higher, and even more preferably an amount that results in a pH of 9.0 or higher.
本発明の尿中カロテノイド濃度を検出する尿検査方法は、治療的、非治療的のいずれでもよい。治療的とは、医療機関での治療、検査等と併用して使用するものであり、非治療的とは、医療行為を含まない概念、すなわち人間を手術、治療又は診断する方法を含まない概念、より具体的には医師又は医師の指示を受けた者が人間に対して手術、治療又は診断を実施する方法を含まない概念である。 The urine testing method of the present invention for detecting urinary carotenoid concentrations may be either therapeutic or non-therapeutic. Therapeutic refers to use in conjunction with treatment, testing, etc. at a medical institution, while non-therapeutic refers to a concept that does not include medical procedures, i.e., a concept that does not include methods of surgery, therapy, or diagnosis on humans; more specifically, a concept that does not include methods of surgery, therapy, or diagnosis performed on humans by a physician or a person under the direction of a physician.
本発明において、尿を採取するタイミングとして、特に限定されるものではないが、1日の中で最初に食事を摂取するまでに採取することが好ましく、起床後すぐ(早朝)に採取する第1尿が特に好ましい。尿中成分濃度は、食事や水分摂取、発汗などの影響を受けやすく、そのときの尿量によって大きく変動するため、同時に測定したクレアチニン値との比率を求めるクレアチニン補正を行うこともできる。 In the present invention, the timing of urine collection is not particularly limited, but it is preferable to collect urine before the first meal of the day, and it is particularly preferable to collect the first urine immediately after waking up (early morning). Since the concentrations of urine components are easily affected by food, water intake, sweating, etc. and vary greatly depending on the amount of urine at that time, a creatinine correction can be performed to determine the ratio with the creatinine value measured at the same time.
本発明の尿検査方法により、尿中カロテノイド濃度をより正確に検出することができる。そして、本発明の尿検査方法で検出した尿中カロテノイド濃度は、血清中カロテノイド濃度、野菜摂取量と高い相関を備えているため、本発明の尿検査方法で検出した尿中カロテノイド濃度により、血清中カロテノイド濃度、野菜摂取量を精度良く推定することができる。 The urinary carotenoid concentration can be detected more accurately using the urinary test method of the present invention. Furthermore, since the urinary carotenoid concentration detected using the urinary test method of the present invention is highly correlated with the serum carotenoid concentration and vegetable intake, the serum carotenoid concentration and vegetable intake can be accurately estimated using the urinary carotenoid concentration detected using the urinary test method of the present invention.
<臨床試験方法>
20~60代の健常人22名(男性11名、女性11名)を対象に、背景調査(性別、生年月日、FFQg調査票による一日の野菜摂取量調査アンケート)、尿中のカロテノイド濃度の測定、血清中のカロテノイド濃度の測定を実施した。
以下のとおり、除外規準を設けた。
1)重篤な既往歴及び消化管の切除手術歴がある方(虫垂切除を除く)
2)妊娠している方及び授乳中の方
3)アルコール多飲及び過度の喫煙の方
4)その他、試験責任医師により本試験参加に不適切と判断された方
<Clinical trial method>
Twenty-two healthy individuals (11 men and 11 women) in their 20s to 60s were surveyed for background information (gender, date of birth, and questionnaire on daily vegetable intake using the FFQg questionnaire), and carotenoid concentrations in urine and serum were measured.
The exclusion criteria were as follows:
1) Those with a serious medical history or a history of gastrointestinal surgery (excluding appendectomy)
2) Pregnant or breastfeeding women 3) Those who drink a lot of alcohol or smoke excessively 4) Others who are deemed inappropriate to participate in this study by the investigator
本試験は倫理的配慮として、倫理審査委員会に当該試験を行うことの適否についての審査を受け、本臨床試験の実施に際しては、事前に被検者全員に試験の主旨を十分に説明したうえで、本人の自由意思で書面による参加の同意を得た。被検者は、来院日の第1尿を採尿し、来院日の午前中に病院にて採血を受けた。 As an ethical consideration, the appropriateness of conducting this study was reviewed by the Institutional Review Committee, and prior to conducting this clinical trial, the purpose of the study was fully explained to all subjects, and written consent to participate was obtained from each subject. Subjects collected their first urine sample on the day of their visit, and had their blood drawn at the hospital in the morning of the day of their visit.
(採尿)
試験日の早朝第1尿(起床後すぐの尿)を自宅で200mL採取し、試験会場に持参させた。
(尿中カロテノイド濃度の定量)
・添加剤
以下の8種類の添加剤を用いた。
On the day of the test, participants were asked to collect 200 mL of their first urine (immediately after waking up) at home and bring it to the test site.
(Quantitative determination of urinary carotenoid concentrations)
Additives The following eight types of additives were used.
5mLチューブに尿1mLと上記添加剤のいずれか100μL添加した。
1名の被検者(以下、被検者Aという)の尿について、添加前後での沈殿の変化を目視で確認した。また、pH試験紙を用いて添加後のpHを測定した。結果を表2に示す。なお、pHについて幅がある記載となっているサンプルは、pH試験紙の色を目視で確認したため、正確な判別が難しかったものである。
The urine of one subject (hereinafter referred to as Subject A) was visually observed for changes in precipitate before and after the addition. The pH after the addition was also measured using pH test paper. The results are shown in Table 2. For samples with a range of pH values, accurate determination was difficult because the color of the pH test paper was visually checked.
その後0.1%BHT(ジブチルヒドロキシトルエン)/エタノール溶液を2mL加えて振とうし、室温で5分間静置した。内部標準の0.1ppbアポカロテナールを10μLと、ヘキサン2mLを加えて振とうし、遠心分離(3000rpm 5分)した。遠心分離後の上清を4/5分取し、遠心エバポレーターで45℃に加温し乾燥させ、0.1%BHT/エタノール溶液100μLで溶解して尿検体を得た。 2 mL of 0.1% BHT (dibutylhydroxytoluene)/ethanol solution was then added, the mixture was shaken, and allowed to stand at room temperature for 5 minutes. 10 μL of the internal standard 0.1 ppb apocarotenal and 2 mL of hexane were added, the mixture was shaken, and centrifuged (3000 rpm for 5 minutes). After centrifugation, 4/5 of the supernatant was collected, heated to 45°C in a centrifugal evaporator, dried, and dissolved in 100 μL of 0.1% BHT/ethanol solution to obtain the urine sample.
尿検体を、下記条件でHPLCに供し、尿中カロテノイド濃度を定量した。
(カラム)
ACQUITY UPLC BEH C18Column、1.7μm、2.1mm×150mm(Waters社製)
(分析条件)
装置 UHPLC(Nexera X2シリーズ、島津製作所社製)
移動相 アセトニトリル:メタノール=9:1
流速 0.50mL/分
カラム温度 40℃
注入量 5μL
検出波長 450nm
The urine samples were subjected to HPLC under the following conditions to quantify the carotenoid concentrations in urine.
(column)
ACQUITY UPLC BEH C18 Column, 1.7 μm, 2.1 mm × 150 mm (Waters)
(Analysis conditions)
Apparatus: UHPLC (Nexera X2 series, manufactured by Shimadzu Corporation)
Mobile phase: acetonitrile:methanol = 9:1
Flow rate: 0.50 mL/min Column temperature: 40°C
Injection volume 5μL
Detection wavelength: 450 nm
被検者Aの添加剤毎の尿検体のHPLCクロマトグラフを図1に示す。また、被検者Aの尿について、同様にして3個の検体を作成して分析したHPLCクロマトグラフのβカロテンの面積値の平均値を図2に示す。
アルカリ性添加剤を添加剤として添加することにより、カロテノイドの検出強度が上昇した。特に、水酸化ナトリウム、水酸化カリウム、トリス(ヒドロキシメチル)アミノメタン、イミダゾール、アルギニンにより、検出強度が顕著に上昇した。
The HPLC chromatograms of the urine samples of subject A for each additive are shown in Figure 1. Three urine samples of subject A were prepared in the same manner and analyzed, and the average area values of the β-carotene in the HPLC chromatograms are shown in Figure 2.
The detection intensity of carotenoids increased with the addition of alkaline additives, especially sodium hydroxide, potassium hydroxide, tris(hydroxymethyl)aminomethane, imidazole, and arginine.
(採血)
試験日の午前中、9mLの血液を添加剤なしの採血管に採取し、血液凝固を確認した後遠心分離(3000rpm 10分)し、血清を得た。
(血清中カロテノイド濃度の定量)
血清中のカロテノイド濃度は、株式会社エスアールエルに分析を委託し、HPLC法で分析した。
(Blood collection)
In the morning of the test day, 9 mL of blood was collected in a blood collection tube without any additives, and after confirming blood coagulation, the blood was centrifuged (3000 rpm for 10 minutes) to obtain serum.
(Quantification of serum carotenoid concentrations)
The carotenoid concentration in the serum was analyzed by HPLC by SRL Co., Ltd.
・相関1
尿中βカロテン濃度と血清中βカロテン濃度、および尿中βカロテン濃度とFFQg調査票による一日の野菜摂取量を、一元配置分散分析して決定係数を求めた。結果を表3に示す。
The coefficient of determination was calculated by one-way analysis of variance between the urinary β-carotene concentration and serum β-carotene concentration, and between the urinary β-carotene concentration and the daily vegetable intake measured by the FFQg questionnaire. The results are shown in Table 3.
尿素、アルギニンを添加することにより、添加なしと比較して、決定係数が大きくなり(1に近づく)、特にアルギニンを添加した場合に高い相関を示した。また、尿中βカロテン濃度は、血清中βカロテン濃度と比較して野菜摂取量とより高い相関を示した。このことから、添加剤により尿をアルカリ性とすることにより、尿中カロテノイド濃度をより正確に測定することができ、測定した尿中カロテノイド濃度から、血清中カロテノイド濃度と野菜摂取量とを高い精度で推定できることが確認できた。 By adding urea and arginine, the coefficient of determination increased (approaching 1) compared to when no additions were made, and a particularly high correlation was observed when arginine was added. Furthermore, urinary beta-carotene concentration showed a higher correlation with vegetable intake than serum beta-carotene concentration. This demonstrates that by making urine alkaline with additives, urinary carotenoid concentrations can be measured more accurately, and that serum carotenoid concentrations and vegetable intake can be estimated with high accuracy from the measured urinary carotenoid concentrations.
・相関2
尿中カロテン総量(αカロテン+βカロテン)濃度と血清中βカロテン濃度、および尿中カロテン総量濃度とFFQg調査票による一日の野菜摂取量を、一元配置分散分析して決定係数を求めた。結果を表4に示す。
The coefficient of determination was calculated by one-way analysis of variance between the urinary total carotene (α-carotene + β-carotene) concentration and serum β-carotene concentration, as well as between the urinary total carotene concentration and the daily vegetable intake measured by the FFQg questionnaire. The results are shown in Table 4.
尿素、アルギニンを添加することにより、添加なしと比較して、決定係数が大きくなり(1に近づく)、特にアルギニンを添加した場合に高い相関を示した。また、尿中βカロテン濃度と同じく、尿中カロテン総量も血清中βカロテン濃度と比較して野菜摂取量とより高い相関を示した。このことから、添加剤により尿をアルカリ性とすることにより、尿中カロテノイド濃度をより正確に測定することができ、測定した尿中カロテノイド濃度から、血清中カロテノイド濃度と野菜摂取量とを高い精度で推定できることが確認できた。 By adding urea and arginine, the coefficient of determination increased (approaching 1) compared to when no additions were made, and a particularly high correlation was observed when arginine was added. Furthermore, like urinary beta-carotene concentration, total urinary carotene also showed a higher correlation with vegetable intake compared to serum beta-carotene concentration. This demonstrates that by making urine alkaline with additives, urinary carotenoid concentrations can be measured more accurately, and that serum carotenoid concentrations and vegetable intake can be estimated with high accuracy from the measured urinary carotenoid concentrations.
Claims (3)
前記アルカリ性添加剤がイミダゾールまたはアルギニンであり、
尿中カロテノイド濃度測定用であり、尿採取後のpHが8.5以上となることを特徴とする採尿キット。 A urine collection container and an alkaline additive are included,
the alkaline additive is imidazole or arginine;
A urine collection kit for measuring urinary carotenoid concentration , characterized in that the pH of urine collected is 8.5 or higher .
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021082147 | 2021-05-14 | ||
| JP2021082147 | 2021-05-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022176095A JP2022176095A (en) | 2022-11-25 |
| JP7797759B2 true JP7797759B2 (en) | 2026-01-14 |
Family
ID=84145261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022063757A Active JP7797759B2 (en) | 2021-05-14 | 2022-04-07 | Urinary carotenoid testing method, urine collection kit, and method for estimating serum carotenoid concentration or vegetable intake |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7797759B2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001059462A1 (en) | 2000-02-08 | 2001-08-16 | International Reagents Corporation | Method of measuring lipid components and method of examining renal failure |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0949507A4 (en) * | 1996-12-26 | 2000-03-22 | Fuji Yakuhin Kogyo Kk | Agent for treating urine specimen |
-
2022
- 2022-04-07 JP JP2022063757A patent/JP7797759B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001059462A1 (en) | 2000-02-08 | 2001-08-16 | International Reagents Corporation | Method of measuring lipid components and method of examining renal failure |
Non-Patent Citations (1)
| Title |
|---|
| 大嶋俊二,尿中および血漿中のカロテノイド濃度の相関性,The Vitamin Society of Japan,2001年,75巻4号,p211,DOI:10.20632/vso.75.4_211_2 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022176095A (en) | 2022-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tanumihardjo | Assessing vitamin A status: past, present and future | |
| Marreiro et al. | Zinc nutritional status in obese children and adolescents | |
| Ylönen et al. | Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study | |
| Błażewicz et al. | Serum and urinary selenium levels in obese children: a cross-sectional study | |
| Wu et al. | The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results | |
| Haskell et al. | Population-based plasma kinetics of an oral dose of [2H4] retinyl acetate among preschool-aged, Peruvian children | |
| Emmanuelle et al. | Selenium exposure in subjects living in areas with high selenium concentrated drinking water: Results of a French integrated exposure assessment survey | |
| Tang et al. | Toxic effects of trace elements on newborns and their birth outcomes | |
| Bergsland et al. | Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones | |
| Hild | Folate losses from the skin in exfoliative dermatitis | |
| JP7797759B2 (en) | Urinary carotenoid testing method, urine collection kit, and method for estimating serum carotenoid concentration or vegetable intake | |
| Kimber et al. | The pathogenesis of iron deficiency anemia following partial gastrectomy: a study of iron balance | |
| JP4694474B2 (en) | Method for testing fat-soluble vitamins and / or fat-soluble food factors by saliva analysis | |
| CN105188695A (en) | Treatment of insulin resistance associated with prolonged physical inactivity | |
| Ahmad et al. | A review Hair tissue analysis: an analytical method for determining essential elements, toxic elements, hormones and drug use and abuse | |
| Quadro | A gold standard to accurately assess vitamin A status: are we there yet? | |
| Cruz-Chamorro et al. | Alcoholic fermentation with Pichia kluyveri could improve the melatonin bioavailability of orange juice | |
| VANNUCCHI et al. | Assessment of zinc nutritional status of pellagra patients | |
| Rahdar et al. | Comparison of some electrolytes in hydatid cyst fluid and serum of liver hydatidosis of sheep. | |
| Dutta et al. | A study on assessment of HbA1c level as a diagnostic criterion of type 2 diabetes mellitus | |
| Jadhav et al. | Estimation of calcium contents and its bioaccessibility in different calcium tablets | |
| Singhatas et al. | Prospective cohort study of serum selenium in surgical ICU patients | |
| Abdullah et al. | Determination of serum zinc, manganese, copper and cobalt traces in type two diabetic patients in Sulaimaniyah city using icp technique | |
| JP7379767B2 (en) | Non-invasive method for estimating serum zinc levels | |
| Lakshmi et al. | Association of serum iron and total iron binding capacity in rural children |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20241114 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250829 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250902 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251007 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20251125 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251126 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7797759 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |